Form 4 for ASMB ASSEMBLY BIOSCIENCES, INC.
Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-22 · accession 0001209191-23-031912 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-24 | 2023-05-23 | ASMB | Delaney William E IV | CSO | S - Sale | $1.04 | -6,561 | 116.4K | -5% | -$6,823 | |
| 2023-05-24 | 2023-05-22 | ASMB | Delaney William E IV | CSO | A - Grant | $0.00 | +35.0K | 123.0K | +40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-23 | S | D | 6,561 | $1.04 | 116,437 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.02 to $1.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. |
| 2 | Common | Common Stock | 2023-05-22 | A | A | 35,000 | $0.00 | 122,998 | D | — | — | (F1) Represents shares of common stock issuable under a performance-based restricted stock unit award dated July 22, 2021. On May 22, 2023, the performance-based vesting conditions were achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: May 22, 2023 and May 22, 2024. (F2) Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on May 12, 2023. |